Transforming big pharma assessing the strategic alternatives /
Transforming Big Pharma addresses critically how strategy works in the pharmaceutical industry. John Ansell assesses the wide range of alternative strategies big pharma has been attempting in order to make up the shortfall in revenues stemming from the long-standing failure to develop sufficient new...
| Основен автор: | Ansell, John, 1947- |
|---|---|
| Формат: | Електронен |
| Език: | English |
| Публикувано: |
Farnham, Surrey :
Gower Publishing Limited,
[2013]
|
| Предмети: | |
| Онлайн достъп: |
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=620348 |
| Подобни документи: |
Print version::
Transforming big pharma. |
| Резюме: |
Transforming Big Pharma addresses critically how strategy works in the pharmaceutical industry. John Ansell assesses the wide range of alternative strategies big pharma has been attempting in order to make up the shortfall in revenues stemming from the long-standing failure to develop sufficient new products. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Whilst diversification may have some value as a stopgap, big pharma companies risk squandering their resources in directions that can only make. |
|---|---|
| Физически характеристики: |
1 online resource : illustrations. |
| Библиография: |
Includes bibliographical references and index. |
| ISBN: |
9781409448280 1409448282 9781299925113 1299925111 |